CALC
CalciMedica, Inc.
Key Financials
Operating Income
$-23121000
↑ 4.5%
Net Income
$-29562000
↓ 115.8%
Total Liabilities
$20.2M
↑ 275.8%
Cash & Equivalents
$11.5M
↑ 45.2%
EPS (Diluted)
$-1.97
↓ 61.5%
Shareholders' Equity
$-6641000.00
↓ 146.1%
Total Assets
$13.6M
↓ 31.3%
Operating Cash Flow
$-21178000.00
↓ 0.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G | 8/14/2026 | View on SEC |
| SCHEDULE 13G | 8/14/2026 | View on SEC |
| 10-Q | 8/11/2026 | View on SEC |
| 8-K | 8/11/2026 | View on SEC |
| EFFECT | 7/31/2026 | View on SEC |
| S-3 | 7/24/2026 | View on SEC |
| ARS | 7/23/2026 | View on SEC |
| DEF 14A | 7/23/2026 | View on SEC |
| SCHEDULE 13G | 7/20/2026 | View on SEC |
| PRE 14A | 7/13/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CALC |
| Company Name | CalciMedica, Inc. |
| CIK | 1534133 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 858-952-5500 |